[Pj-016] Japanese Poster Session 016

[Pj-016-1] RAISE-XT: Safety and tolerability of zilucoplan in patients with myasthenia gravis [Encore Presentation]

Hiroyuki Murai^1,12, Masayuki Masuda^2,12, Angela Genge^3,12, Yessar Hussain^4,12, Henry J. Kaminski^5,12, M. Isabel Leite^6,12, Renato Mantegazza^7,12, Kimiaki Utsugisawa^8,12, Tuan Vu^9,12, Melissa Brock¹⁰, Babak Boroojerdi¹⁰, Mark Vanderkelen¹⁰, Guillemette De La Borderie¹⁰, Petra W. Duda¹⁰, James F. Howard Jr.^11,12 (1.Department of Neurology, International University of Health and Welfare, Japan, 2.1Department of Neurology, Tokyo Medical University, Japan, 3.Clinical Research Unit, The Montreal Neurological Institute, Canada, 4.Department of Neurology, Dell Medical School, The University of Texas at Austin, USA, 5.George Washington University, Washington, USA, 6.Nuffield Department of Clinical Neurosciences, University of Oxford, UK, 7.Neuroimmunology and Neuromuscular Diseases Department, Italy, 8.Department of Neurology, Hanamaki General Hospital, Japan, 9.Department of Neurology, University of South Florida Morsani College of Medicine, USA, 10.UCB Pharma, Other country, 11.Department of Neurology, The University College of North Carolina at Chapel Hill, USA, 12.RAISE Study Investigators, Other country)